<p><strong>Implantable Insulin Pumps Market</strong> Size, Share, Trends, Scope, Statistics, <strong>By Pump Type</strong>&nbsp;(Programmable Implantable Pumps, Closed-loop Pumps, Open-loop Pumps, Non-programmable Implantable Pumps, Others (Hybrid Delivery Systems)),&nbsp;<strong>By Reservoir Size</strong>&nbsp;(Small Volume (&le;10 mL), Medium Volume (10&ndash;20 mL), Large Volume (&gt;20 mL), Others),&nbsp;<strong>By Delivery Mode</strong>&nbsp;(Continuous Basal Delivery, Bolus Delivery, Combined Basal-Bolus Delivery, Others),&nbsp;<strong>By End User</strong>&nbsp;(Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Diabetes Clinics, Homecare Settings, Others (Military, Research)),&nbsp;<strong>By Age Group</strong>&nbsp;(Pediatric (&le;17 years), Adults (18&ndash;64 years), Geriatric (&ge;65 years)),&nbsp;<strong>By Indication</strong>&nbsp;(Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM), Others (e.g., LADA, MODY)),&nbsp;<strong>By Distribution Channel</stron

Implantable Insulin Pumps Market Size to Hit USD 11.62 Billion by 2032